Related Experiment Video
Updated: Jun 27, 2026

Methods to Increase the Sensitivity of High Resolution Melting Single Nucleotide Polymorphism Genotyping in Malaria
Published on: November 10, 2015
Identification of genetic mutations associated with attenuation and changes in tropism of Urabe mumps virus
Dion Shah1, Silvia Vidal, Malen A Link
1Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada.
Abstract:
Although several effective mumps virus vaccines have been developed, almost nothing is known about the genetic changes responsible for loss of virulence. One vaccine, Urabe AM9, was withdrawn from the market because of insufficient attenuation. The vaccine was found to contain a mixture of viruses that could be distinguished based on the sequence of the hemagglutinin-neuraminidase gene (HN). Viruses containing lysine at HN amino acid position 335 were isolated from cases of post-vaccination parotitis or meningitis whereas viruses containing glutamic acid at this position were not associated with post-vaccination disease. Using a rat based model of mumps neurovirulence, we demonstrate that this latter virus is significantly attenuated compared to a virus isolated from a patient with post-vaccination meningitis. Complete sequence analysis of the genomes of the two viruses identified sixteen genetic differences, some or all of which must be responsible for differences in virulence. These same genetic differences also account for changes in tropism in cell culture.
Insights
Genetic changes in the mumps virus hemagglutinin-neuraminidase gene (HN) impact virulence. A specific HN mutation (lysine at position 335) is linked to vaccine-associated disease, while another (glutamic acid) shows attenuation.
Area of Science:
- Virology
- Vaccinology
- Molecular Biology
Background:
- Mumps virus vaccines are effective, but genetic determinants of reduced virulence are poorly understood.
- The Urabe AM9 mumps vaccine was withdrawn due to insufficient attenuation and associated adverse events.
- The Urabe AM9 vaccine contained a mixture of viruses differing in the hemagglutinin-neuraminidase (HN) gene sequence.
Purpose of the Study:
- To investigate the genetic basis for differences in mumps virus virulence and attenuation.
- To correlate specific genetic changes in the HN gene with mumps virus neurovirulence and vaccine-associated disease.
Main Methods:
- Comparative sequencing of the hemagglutinin-neuraminidase (HN) gene from vaccine strains.
- Utilizing a rat model to assess mumps virus neurovirulence.
- Complete genome sequencing of attenuated and virulent mumps virus strains.
Main Results:
- Viruses with lysine at HN amino acid position 335 were associated with post-vaccination meningitis.
- Viruses with glutamic acid at HN position 335 were attenuated in a rat neurovirulence model.
- Sixteen genetic differences were identified between attenuated and virulent strains, likely responsible for virulence variations and altered cell tropism.
Conclusions:
- The amino acid at position 335 of the mumps virus HN protein is a key determinant of virulence.
- Genetic variations identified contribute to differences in mumps virus neurovirulence and tropism.
- Understanding these genetic changes is crucial for developing safer and more effective mumps vaccines.
Related Concept Videos
Viral Mutations
Mutations in Microorganisms

